| NCT06733935 | NKX019, Intravenous Allogeneic Chimeric Antigen Receptor Natural Killer Cells (CAR NK), in Participants With Immune-Mediated Diseases (Ntrust-2) | RECRUITING | PHASE1 | 2024-11-04 | 2028-10 | 2028-10 |
| NCT06557265 | NKX019, Intravenous Allogeneic Chimeric Antigen Receptor Natural Killer Cells (CAR NK), in Adults With Autoimmune Disease (Ntrust-1) | RECRUITING | PHASE1 | 2024-06-13 | 2027-04 | 2027-04 |
| NCT05020678 | NKX019, Intravenous Allogeneic Chimeric Antigen Receptor Natural Killer Cells (CAR NK), in Adults With B-cell Cancers | ACTIVE_NOT_RECRUITING | PHASE1 | 2021-08-20 | 2038-12 | 2025-03 |
| NCT04623944 | NKX101, Intravenous Allogeneic CAR NK Cells, in Adults With AML or MDS | ACTIVE_NOT_RECRUITING | PHASE1 | 2020-09-21 | 2039-07 | 2024-10-02 |